Regulation of steroid glucuronosyltransferase activities and transcripts by androgen in the human prostatic cancer LNCaP cell line

Endocrinology

Volumn 137, Issue 7, 1996, Pages 2872-2879

  Guillemette, Chantal ^a   Hum, Dean W ^a   Bélanger, Alain ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROSTANOLONE; ANTIANDROGEN; BICALUTAMIDE; ESTROGEN; GLUCURONOSYLTRANSFERASE; METRIBOLONE;

ANDROGEN SYNTHESIS; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME REGULATION; GLUCURONIDATION; HORMONAL REGULATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; TRANSCRIPTION REGULATION;

EID: 0029953793     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.137.7.8770908     Document Type: Article

References (53)

1. Jost A 1953 Problems of fetal endocrinology: the gonadal and hypophyseal hormones. Recent Prog Horm Res 8:379-381
2. Ghanadian R 1983 Hormonal environment of the normal prostate. In: Ghanadian R (ed) The Endocrinology of the Prostate Tumours. MTP Press, Lancaster, pp 35-41
3. Wilding G 1995 Endocrine control of prostate cancer. Cancer Surg 23:43-62
4. Huggins C, Hodges CV 1941 Studies of prostatic cancer. The effect of castration of estrogen and of androgen injection on serum phosphates in metastatic carcinoma of the prostate. Cancer Res 1:293-297
5. Krieg M 1984 Biochemical endocrinology of human prostatic tumors. In: Bresciani F, King RJB, Lippman ME, Namer M, Raynaud JP (eds) Progress in Cancer Research Therapy. Raven Press, New York, vol 31:425-440
6. Coffey DS, Berry SJ, Ewing LL 1985 An overview of current concepts in the study of benign prostatic hyperplasia. In: Rodgers CH, Coffey DS, Cunha G, Grayback JT, Hinman F, Horton R (eds) Benign Prostatic Hyperplasia. NIH, Bethesda, publication 87-2881, vol 2:1-13
7. Labrie F, Luthy I, Veilleux R, Simard J, Bélanger A, Dupont A 1987 New concepts on the androgen sensitivity of prostate cancer. In: Murphy GP, Khoury S, Kuss R, Chatelain C, Denis L (eds) Progress in Clinical and Biological Research. Prostate Cancer, part A. Liss, vol 243A:145-172
8. Wilding G 1992 The importance of steroid hormones in prostate cancer. Cancer Surg 14:113-130
9. Bélanger B, Bélanger A, Labrie F, Dupont A, Cusan L, Monfette G 1989 Comparison of residual C-19 steroids in plasma and prostatic tissue of human, rat and guinea pig after castration: unique importance of extratesticular androgens in men. J Steroid Biochem Mol Biol 32:695-698
10. Labrie F, Dupont A, Bélanger A 1985 Complete androgen blockade for the treatment of prostate cancer. In: de Vita VT, Hellman S, Rosenberg SA (eds) Important Advances in Oncology. Lippincott, Philadelphia, pp 193-217
11. Labrie F 1991 Intracrinology. Mol Cell Endocrinol 78:C113-C118
12. Bélanger A, Brochu M 1986 Levels of plasma steroid glucuronides in intact and castrated men with prostatic cancer. J Clin Endocrinol Metab 62:812-815
13. Brochu M, Bélanger A 1987 Increase in plasma steroid glucuronide levels in men from infancy to adulthood. J Clin Endocrinol Metab 64:1283-1287
14. Bélanger A 1993 Determination of non-conjugated and conjugated steroids in human plasma. In: Görög S (ed) Proceedings of the Fifth Symposium on the Analysis of Steroids, Szombathely, Akadémiai Kiado, Budapest, Hungary, pp 99-110
15. Russell DW, Wilson JD 1994 Steroid 5α-reductase: two genes/two enzymes. Annu Rev Biochem 63:25-61
16. Lacoste D, Bélanger A, Labrie F 1990 Biosynthesis and degradation of androgens in human prostate cancer cell lines. Ann NY Acad Sci 595:389-391
17. Harper ME, Pike A, Peeling WB, Griffiths K 1974 Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro. J Endocrinol 60:117-125
18. Bélanger A, Candas B, Dupont A, Cusan L, Diamond P, Gomez JL, Labrie F 1994 Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80- year-old men. J Clin Endocrinol Metab 79:1086-1090
19. Abalain JH, Quemener E, Carre JL, Simon B, Amet Y, Mangin P, Floch HH 1989 Metabolism of androgens in human hyperplastic prostate: evidence for differential localization of the enzymes involved in the metabolism. J Steroid Biochem Mol Biol 34:467-471
20. Martel C, Rhéaume E, Takahashi M, Trudel C, Couet J, Luu-The V, Simard J, Labrie F 1992 Distribution of 17β-hydroxysteroid dehydrogenase gene expression, activity in rat and human tissues. J Steroid Biochem Mol Biol 41:597-603
21. Guillemette C, Bélanger A 1995 Glucuronosyltransferase activity in the human cancer cell line LNCaP. Mol Cell Endocrinol 107:131-139
22. Bélanger A, Couture J, Caron S, Roy R 1990 Determination of non-conjugated and conjugated steroid levels in plasma and prostate after separation on C-18 columns. Ann NY Acad Sci 595:251-259
23. Chen F, Ritter JK, Wang MG, McBridge W, Lubet RA, Owens IS 1993 Characterization of a cloned human dihydrotestosterone/androstanediol UDP-glucuronosyltransferase and its comparison to other steroid isoforms. Biochem J 32:10648-10657
24. Bélanger G, Beaulieu M, Marcotte B, Levesque E, Guillemette C, Hum DW, Bélanger A 1995 Expression of transcripts encoding steroid UDP-glucuronosyltransferases in human prostate hyperplastic tissue and the LNCaP cell line. Mol Cell Endocrinol 113:165-173
25. Berns EM, de Boer W, Mulder E 1986 Androgen-dependent growth regulation of and release of specific protein(s) by the androgen receptor containing human tumor cell line LNCaP. Prostate 9:247-259
26. Sonnenschein C, Olea N, Pasanen ME, Soto AM 1989 Negative controls of cell proliferation: human prostate cancer cells and androgens. Cancer Res 49:3474-3481
27. Belanget C, Veilleux R, Labrie F 1990 Stimulatory effects of androgens, estrogens, progestins, and dexamethasone on the growth of the LNCaP human prostate cancer cells. Ann NY Acad Sci 595: 399-402
28. Simard J, Veilleux R, de Launoit Y, Haagensen DE, Labrie F 1991 Stimulation of apolipoprotein D secretion by steroids coincide with inhibition of cell proliferation in LNCaP prostate cancer cells. Cancer Res 51:4336-4342
29. Henttu P, Liao S, Vihko P 1992 Androgens up-regulate the human prostate-specific antigen messager ribonucleic acid (mRNA), but down-regulate the prostatic acid phosphatase mRNA in the LNCaP cell line. Endocrinology 130:766-777
30. Guillemette C, Hum DW, Bélanger A 1995 Specificity of glucuronosyltransferase activity in the human cancer cell line LNCaP, evidence for the presence of at least two glucuronosyltranferase enzymes. J Steroid Biochem Mol Biol 55:355-362
31. Guillemette C, Hum DW, Bélanger A 1996 Evidence for a role of glucuronosyltransferase in the regulation of androgen action in the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 57:225-231
32. Damassa DA, Lin TM, Sonnenschein C, Soto AM 1991 Biological effects of sex hormone-binding globulin on androgen-induced proliferation and androgen metabolism in LNCaP prostate cells. Endocrinology 129:75-84
33. Mulder GJ 1992 Glucuronidation and its role in regulation of biological activity of drugs. Annu Rev Pharmacol Toxicol 32:25-49
34. van Steenbrugge GJ, Groen M, van Dongen JW, Bolt J, van der Korput H, Trapman J, Hasenson M, Horoszewicz J 1989 The human prostatic carcinoma cell line LNCaP and its derivatives. An overview. J Urol Res 17:71-77
35. Bélanger A, Rong PM, Sha L, Labrie F 1993 Characterization and measurement of prostatic-specific antigen using monoclonal antibodies. Clin Invest Med 16:409-415
36. Kramer CY 1956 Extension of multiple-range test group means with unique numbers of replications. Biometrics 12:307-310
37. Tucker H, Crook JW, Chesterson GJ 1988 Nonsteroidal antiandrogens. Synthesis and structure-activity relationships of 3-substituted derivatives of 2-hydroxypropionanilides. J Med Chem 31:654-659
38. Veldscholte J, Berrevoets CA, Ris-Stalpers C, Kuiper GGJM, Jenster G, Trapman J, Brinkmann AO, Mulder E 1992 The androgen receptor in LNCaP cells contains a mutation in the ligand binding domain which affects steroid binding characteristic and response to antiandrogens. J Steroid Biochem Mol Biol 41:665-669
39. Veldscholte J, Berrevoets CA, Brinkmann AO, Grootegoed JA, Mulder E 1992 Anti-androgens and the mutated androgen receptor of LNCaP cells: differential effects on binding affinity, heat-shock protein interation, and transcription activation. Biochem J 31:2393-2399
40. Berrevoets CA, Veldschotte J, Mulder E 1993 Effects of antiandrogens on transformation and transcription activation of wild type and mutated (LNCaP) androgens receptors. J Steroid Biochem Mol Biol 46:731-736
41. Veldseholte J, Berrevoets CA, Mulder E 1994 Studies on the human prostatic cancer cell line LNCaP. J Steroid Biochem Mol Biol 49-341-346
42. Kuil CW, Mulder E 1994 Mechanism of antiandrogen action: conformational changes of the receptor. Mol Cell Endocrinol 102:R1-R4
43. Green M, Eyitayo MO, Tephly RT 1994 Stable expression of a human liver UDP-glucuronosyltransferase (UGT2B15) with activity toward steroid and xenobiotic substrates. Drug Metab Disp 22:799-805
44. Mauvais-Jarvis P, Charransol G, Bobas-Masson F 1973 Simultaneous determination of urinary androstanediol and testosterone as an evaluation androgenicity. J Clin Endocrinol Metab 36:452-459
45. Horton R, Lobo R 1986 Peripheral androgens and the role of androstanediol glucuronide. J Clin Endocrinol Metab 15:293-306
46. Brochu M, Belanger A, Tremblay RR 1987 Plasma levels of C-19 steroids and 5α-reduced steroid glucuronides in hyperandrogenic and idiopathic hirsute women. Fertil Steril 48:948-953
47. Lookingbill DP, Egan N, Santen RJ, Demers LM 1988 Correlation of serum 3α-androstanediol glucuronide with acne and chest hair density in men. J Clin Endocrinol Metab 67:986-991
48. Bélanger A, Brochu M, Lacoste D, Noel C, Labrie F, Dupont A, Cusan L, Caron S, Couture J 1991 Steroid glucuronides: human circulatory levels and formation by LNCaP cells. J Steroid Biochem Mol Biol 40:593-598
49. Pang S, MacGillivray M, Wang M, Jeffries S, Clark A, Rosenthal I, Wiegensberg M, Riddick L 1991 3α-Androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion. J Clin Endocrinol Metab 73:166-174
50. Carmina E, Lobo RA 1993 Evidence for increased androsterone metabolism in some normoandrogenic women with acne. J Clin Endocrinol Metab 76:1111-1114
51. Brochu M, Bélanger A, Dupont A, Cusan L, Labrie F 1987 Effects of flutamide and aminoglutethimide on plasma 5α-reduced steroid glucuronide concentrations in castrated patients with cancer of the prostate. J Steroid Biochem 28:619-622
52. Kashfi K, Yang EK, Chowdhury JR, Chowdhury NR, Dannenberg AJ 1994 Regulation of uridine diphosphate glucuronosyltransferase expression by phenolic antioxidants. Cancer Res 54:5856-5859
53. Munzel PA, Bruck M, Bock KW 1993 Tissue-specific constitutive and inducible expression of rat phenol UDP-glucuronosyltransferase. Biochem Pharmacol 47:1445-1448